Smaller sibling protein calls the shots in cell division

January 3, 2012
Scientists have found at least one instance when the smaller sibling gets to call the shots and cancer patients may one day benefit. Credit: Phil Jones, GHSU Photographer

Scientists have found at least one instance when the smaller sibling gets to call the shots and cancer patients may one day benefit.

The protein Chk1 has long been known to be a in cell development: it keeps normal cells and damaged cells from dividing until their DNA has been fully replicated or repaired. Now scientists at Georgia Health Sciences University and the California Institute of Technology have discovered a shorter form they've dubbed Chk1-S ("S" stands for short) that essentially neutralizes its longer sibling so cell division can proceed.

That shorter form is in higher levels in as well as , both of which require accelerated cell division. But the scientists also have shown that very high levels of Chk1-S actually reduce and prompt premature cell division and death in other cells.

"Chk1 is needed for division of all cells, even cancer cells, so if you inhibit it completely by over-expressing Chk1-S, those cells also will not grow," said Dr. Navjotsingh Pabla, a at Caltech. Chk1-S expression is nearly zero in normal, non-dividing cells.

These findings, published in , point toward the short form's potential to help diagnose and/or treat cancer, they said. Chk1 inhibitors, which promote abnormal cell division – and likely cell death – to occur before DNA replication/repair is complete, already are being tested on patients.

"Chk1-S is only expressed at a time when DNA is replicated or repaired so it binds to its sibling protein, Chk1, antagonizing it so now the cell can divide," said Dr. Zheng Dong, cell biologist at GHSU and the Charlie Norwood Veterans Affairs Medical Center in Augusta. "The question that has been hanging on for many years is: How is Chk1 regulated?"

They found that significantly increasing levels of Chk1-S induces cell division regardless of whether DNA replication or repair is complete. Incomplete DNA replication or repair can result in spontaneous cell suicide but also can result in chromosomal or genetic defects leading to cancer cell production. Additionally, cancer cells purposefully mutate to resist treatment. Pabla speculates that expression of the shorter version may be awry in cancer cells. "We are very interested in pursuing that."

"It's exciting to have found an important regulator of such an important protein that we think may contribute to cancer as well as its treatment," Dong said.

Chk1 and Chk1-S are made by the same gene they are just spliced differently. One way Chk1 gets turned on is by phosphorylation, or adding phosphate, which can activate or deactivate a protein. The level of phosphorylation of Chk1 is particularly dramatic when DNA repair is needed. Chk1, in turn, works to temporarily halt the cell cycle by phosphorylating another protein. Interestingly, Chk1-S cannot bind to its when Chk1 is phosphorylated. It's known that mental retardation can result from mutation of ATR, a damage-sensing protein that phosphorylates Chk1.

While the biggest burst of cell division occurs during development, it continues lifelong in areas such as the blood, skin and gastrointestinal tract where cell turnover is high. "Lots of tissues need to regenerate," said Dong.

Explore further: Scientists defeat hurdle to eradicating inactive multiple myeloma cells

Related Stories

Scientists defeat hurdle to eradicating inactive multiple myeloma cells

November 14, 2011
Researchers at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that delivers a deadly one-two blow to kill even the most inactive, or cytokinetically quiescent, ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.